Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 9—September 2008

Dispatch

Occurrence and Clinical Relevance of Mycobacterium chimaera sp. nov., Germany

Birgitta SchweickertComments to Author , Oliver Goldenberg, Elvira Richter, Ulf B. Göbel, Annette Petrich, Petra Buchholz, and Annette Moter
Author affiliations: Charité-Universitätsmedizin, Berlin, Germany (B. Schweickert, A. Petrich, U.B. Göbel, P. Buchholz, A. Moter); Transgenomic Ltd., Glasgow, Scotland, UK (O. Goldenberg ); Nationales Referenzzentrum für Mykobakterien am Forschungszentrum, Borstel, Germany (E. Richter);

Main Article

Table 1

Distribution of mycobacterial species and sequevars*

Species, sequevar† Total isolates, 
no. (%), n = 166 Isolates from Charité,‡ no. (%), n = 97 Isolates from NRC,‡ no. (%), n = 69 Odds ratio (p value§)
MAC
MAC-A 143 (86.1) 90 (92.8) 53 (76.8) 3.88 (p = 0.003)
MAC-C 2 (1.2) 1 (1.0) 1 (1.5) ND
MAC-E
1 (0.6)
1 (1.0)
0
ND
Min
Min-A 17 (10.2) 3 (3.1) 14 (20.3) 0.12 (p<0.001)
Min-C 3 (1.8) 2 (2.1) 1 (1.5) ND

*MAC, M. avium complex species; MAC-A, M. chimaera sp. nov.; ND, not done; Min, M. intracellulare; Min-A, M. intracellulare type strain.
†Classification of MAC strains according to the taxonomy of Frothingham and Wilson (3).
‡Charité, Charité University Hospital, Berlin, Germany; NRC, National Reference Center for Mycobacteria, Borstel, Germany.
§χ2 test, software package Stata version 9 (Stata Corporation, College Station, TX, USA).

Main Article

TOP